Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.42 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4205395 | 0.94 | ALDH1A1 (0.49) | CYP19A1ALDH1A1LMNAPRMT1CYP2C9 | |
| SCHEMBL4202181 | 0.89 | ALDH1A1 (0.44) | CYP19A1ALDH1A1LMNAPRMT1CYP2C9 | |
| SCHEMBL4215358 | 0.89 | MAPT (0.52) | ALDH1A1LMNAPRMT1CYP2C9CYP1A2 | |
| SCHEMBL4197372 | 0.87 | ALDH1A1 (0.48) | CYP19A1ALDH1A1LMNACYP2C9CYP2D6 | |
| SCHEMBL4198835 | 0.84 | ALDH1A1 (0.50) | CYP19A1ALDH1A1LMNAPRMT1CYP2C9 | |
| SCHEMBL4205411 | 0.82 | PRMT1 (0.42) | ALDH1A1LMNAPRMT1CYP2C9CYP1A2 | |
| SCHEMBL4216728 | 0.81 | SMN1; SMN2 (0.55) | ALDH1A1LMNACYP2C9CYP1A2CYP2C19 | |
| SCHEMBL4215191 | 0.80 | ALDH1A1 (0.49) | ALDH1A1LMNAMAPTHTTHPGD | |
| SCHEMBL4202188 | 0.80 | CYP2D6 (0.54) | CYP19A1ALDH1A1LMNACYP2C9CYP2D6 | |
| SCHEMBL8322001 | 0.80 | TACR1 (0.38) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7579480-B2 | Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2009-08-25 | — | — | US | disclosed |
| CN-100402508-C | Alkoxytetrazol-1-ylbenzaldehyde compound and process for producing the same | TOYO KASEI KOGYO CO LTD (JP) | 2008-07-16 | — | — | CN | disclosed |
| US-20070060630-A1 | Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2007-03-15 | — | — | US | disclosed |
| CN-1826329-A | Alkoxy- (tetrazol-1-yl) benzaldehyde compound and process for producing the same | TOYO KASEI KOGYO CO LTD (JP) | 2006-08-30 | — | — | CN | disclosed |
| EP-1650198-A1 | ALKOXYTETRAZOL-1-YLBENZALDEHYDE COMPOUND AND PROCESS FOR PRODUCING THE SAME | Toyo Kasei Kogyo Company Limited (JP) | 2006-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060630-A1 | Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same | ALDH7A1, NAT1, ARSA | CYP19A1 496/4885ALDH1A1 4/4885LMNA 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.